Novo Nordisk A/S
NYSE:NVO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novo Nordisk A/S
NYSE:NVO
|
DK |
|
Paychex Inc
NASDAQ:PAYX
|
US |
|
ARC Resources Ltd
TSX:ARX
|
CA |
|
Gecina SA
OTC:GECFF
|
FR |
|
S
|
Somboon Advance Technology PCL
SET:SAT
|
TH |
|
AirIQ Inc
XTSX:IQ
|
CA |
|
I
|
Intrum AB
F:IJU
|
SE |
|
Rentokil Initial PLC
LSE:RTO
|
UK |
|
C
|
Compagnie d'entreprises CFE SA
XBRU:CFEB
|
BE |
|
BioNTech SE
NASDAQ:BNTX
|
DE |
|
B
|
Beneficient
NASDAQ:BENF
|
US |
Intrinsic Value
The intrinsic value for 
Novo Nordisk A/S (NVO) under the Base Case is hidden
USD.
Compared with the current market price of 45.085 USD, the stock appears hidden
.
NVO looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if NVO is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Novo Nordisk A/S.
Fundamental Analysis
Revenue & Expenses Breakdown
Novo Nordisk A/S
Earnings Waterfall
Novo Nordisk A/S
The intrinsic value for Novo Nordisk A/S (NVO) under the Base Case is hidden USD.
Compared with the current market price of 45.085 USD, the stock appears hidden.
